Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,236.19 +13.51 (+0.26%) Dow
39,621.96 +109.12 (+0.28%) Nasdaq
16,397.53 +56.67 (+0.35%) Bitcoin USD
62,815.52 +1,689.73 (+2.76%) CMC Crypto 200
1,293.79 +33.59 (+2.67%)
Acutus Medical, Inc. (AFIB)
- GlobeNewswire
Acutus Medical Reports First Quarter 2024 Financial Results
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024. Recent Highlights: First quarter revenue from Continuing Operations of $3.6 million grew 192% year-over-year, from $1.2 million in the same quarter last year..Operating expenses for continuing operations were $3.3 million, a reduction of 38% compared to the same period last year.Recorded $2.8 million in gain on sale of business, an
- Simply Wall St.
Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022)
Acutus Medical ( NASDAQ:AFIB ) Full Year 2023 Results Key Financial Results Revenue: US$7.16m (down 56% from FY 2022...
- GlobeNewswire
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Recent Highlights: Announced strategic realignment of resources and corporate restructuring on November 8, 2023 with the objective of optimizing financial position and maximizing free cash flow.The Continuing Operations focuses on the implementation of the business model to shift to solely support
